Loading...
•
Jul 03, 2021
Waters Q2 2021 Earnings Report
Waters' second quarter performance in 2021 was strong, with sales growth driven by pharmaceutical and industrial end markets and increased customer demand across key regions.
Key Takeaways
Waters Corporation reported a 31% increase in sales to $682 million in Q2 2021 compared to $520 million in Q2 2020. GAAP EPS increased to $2.69 from $1.98, while non-GAAP EPS increased to $2.60 from $2.10. The company saw strong growth in the pharmaceutical and industrial markets, with sales increasing across all regions.
Sales of $682 million grew 31% as reported and 27% in constant currency.
GAAP EPS of $2.69; non-GAAP EPS of $2.60, a 24% increase from prior year.
Broad-based commercial momentum in pharmaceutical and industrial end markets.
Continued strength in core and new product instrument and chemistry sales.
Waters
Waters
Waters Revenue by Segment
Waters Revenue by Geographic Location
Revenue by Segment
Waters Instrument Systems Revenue
CapyFin.comTA Instrument Systems Revenue
CapyFin.comRevenue by Geographic Location
Asia Revenue
CapyFin.comAmericas Revenue
CapyFin.comEurope Revenue
CapyFin.com Forward Guidance
The Company expects third quarter 2021 constant-currency sales growth in the range of 7% to 9%. Currency translation is expected to increase third quarter sales growth by approximately one percentage point. The Company also expects third quarter 2021 non-GAAP EPS in the range of $2.25 to $2.35.
Revenue & Expenses
Visualization of income flow from segment revenue to net income